AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Irbesartan gets FDA approval as treatment for diabetic nephropathy.

Asia Africa Intelligence Wire

| September 23, 2002 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Chimie Hebdo)

Bristol-Myers Squibb has been granted an additional indication for its irbesartan anthypertensive which …

Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily